Mercer Global Advisors Inc Ionis Pharmaceuticals Inc Transaction History

Mercer Global Advisors Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$43.39 - $51.63 $18,223 - $21,684	-420 Reduced 8.24%	4,676 $237,000
Q3 2023 Nov 13, 2023	SELL	$38.5 - $47.13 $10,279 - $12,583	-267 Reduced 4.98%	5,096 $231,000
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $186,256 - $232,378	5,363 New	5,363 $220,000
Q2 2022 Aug 10, 2022	BUY	$31.71 - $43.0 $171,107 - $232,028	5,396 New	5,396 $200,000
Q1 2020 May 18, 2020	SELL	$41.6 - $63.4 $143,478 - $218,666	-3,449 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $48,088 - $58,286	-893 Reduced 20.57%	3,449 $208,000
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $26,340 - $32,178	-446 Reduced 9.31%	4,342 $260,000
Q2 2019 Aug 14, 2019	BUY	$62.09 - $86.14 $108,595 - $150,658	1,749 Added 57.55%	4,788 $308,000
Q1 2019 Apr 23, 2019	BUY	$52.92 - $81.17 $160,823 - $246,675	3,039 New	3,039 $247,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

Stay updated on Mercer Global Advisors Inc with notifications on news.